Download PDF

Register to download the report. Already a member?

 
 
Sign Up

Or

67053 1513184208HCLSReviewBulgariaDecember2017.pdf
Energy Boardroom

BioNotebook: Medivation, Clovis, Arena 4Q updates; Abide/Celgene discovery deal; 3 new IPO filers, 2 other set terms

02.03.2014 / Scripintelligence

The Nasdaq index closed down just 0.25%, but the Nasdaq Biotechnology Index (NBI) closed down 2.8%. Medivation ended the day 14.9% lower at $71.91 based on the company's conservative revenue forecast for 2014 Xtandi (enzalutamide) sales. The company lost…

LATEST ISSUE

DOWNLOAD

Most Read

X
Download PDF

First Name:

Last Name:

Company:

Position:

Country:

Email: